European shares closed lower on Friday amid concerns of higher interest rates and inflation, prompted by central bank policy decisions thro...

British drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, de...

Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...

The Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...

A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...

The impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials he...

Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. In India, a host...

In India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug.

Under-performance is likely to continue in the quarter to June since the company expects the supply constraints to ease only by the end of ...

Aurobindo Pharma today said it has received approval from the US Food and Drug Administration (USFDA) to sell generic ulcer medicine raniti...

Indian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...

The acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...